摩根士丹利发表研究报告指出华润医疗发布今年上半年利润警告普通股股东应占净利润预计按年下降20%至25%。若剔除与燕化IO

智通财经
Aug 05
摩根士丹利发表研究报告指出华润医疗发布今年上半年利润警告普通股股东应占净利润预计按年下降20%至25%。若剔除与燕化IOT协议相关的2.1亿元补偿基础业务利润将按年下降55%至60%低于市场共识和大摩的预估。大摩予华润医疗目标价3港元评级“减持”。大摩指出公司将利润下降归因于平均医疗保险每次就诊费用减少显示各地区受DRG/DIP 2.0导致的报销压力加剧。大摩认为这对其他依赖公共保险的医院营运商如海吉亚医疗、固生堂、锦欣生殖和爱尔眼科构成负面影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10